Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 48,537 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AS+ Clear all

Conditions: Anxiety, Depression, Stress, Wellbeing, Quality of Life
Interventions: online mental health coaching; Behavioral
Lead sponsor: Nova Southeastern University; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Sexual Transmission of Infection
Interventions: Gardasil Vaccine, Placebo; Biological · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 16 Years to 24 Years · Female only
Enrollment: 406 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Schizophrenia, Impaired Cognition
Interventions: EVP-6124, Placebo; Drug
Lead sponsor: FORUM Pharmaceuticals Inc; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 753 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 38
States / cities: Tucson, Arizona • Anaheim, California • Bellflower, California + 35 more

Conditions: Social Exclusion, Control
Interventions: Ostracism; Behavioral
Lead sponsor: University at Buffalo; Other
Eligibility: 12 Years to 14 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Small Cell Lung Carcinoma
Interventions: figitumumab, Cisplatin (Or Carboplatin), Etoposide; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 34
States / cities: Washington D.C., District of Columbia • Marrero, Louisiana • Metairie, Louisiana + 28 more

Conditions: Acute Ischemic Stroke
Interventions: Intravenous (IV) recombinant human tissue plasminogen activator (rtPA), Solitaire revascularization device; Drug · Device
Lead sponsor: Medtronic Neurovascular Clinical Affairs; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Breast Cancer
Interventions: Social Contact Reminder; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years and older · Female only
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Stroke, Balance; Distorted
Interventions: Body weight support system control group, Body weight support system with balance perturbations; Device
Lead sponsor: Gaylord Hospital, Inc; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Wallingford, Connecticut

Conditions: Refractive Errors, Myopia, Hyperopia
Interventions: Lehfilcon A contact lens, Comfilcon A contact lens; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 3
States / cities: Medina, Minnesota • Granville, Ohio • Memphis, Tennessee

Conditions: Solid Tumor
Interventions: HS-201; Drug
Lead sponsor: Herbert Lyerly; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Intracranial Hemorrhages, Traumatic Brain Injury
Interventions: SENSE Device; Device
Lead sponsor: Sense Diagnostics, LLC; Industry
Eligibility: 22 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Alcohol Drinking
Interventions: Alcohol-Specific Personalized Normative Feedback, Social Media Personalized Normative Feedback; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Scabies
Interventions: spinosad topical suspension, 0.9%, Placebo; Drug · Other
Lead sponsor: ParaPRO LLC; Industry
Eligibility: 4 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Elk Grove, California • Kissimmee, Florida • Miami, Florida + 1 more

Conditions: Physical Activity
Interventions: HeartSteps: A just-in-time intervention for increasing physical activity among sedentary adults.; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 75 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Carcinoma
Interventions: QT Ultrasound Breast Scanner, Questionnaire Administration; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cervical Dystonia
Interventions: Zinc citrate, Placebo; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 89 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Questionnaire Administration, Sotrovimab, Biospecimen Collection; Other · Biological · Procedure
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Physical Activity, Blood Pressure
Interventions: Gentle Jogger, Gentle Jumper; Device
Lead sponsor: Sackner Wellness Products LLC; Industry
Eligibility: 25 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury
Interventions: Web/mobile/tablet-based digital decision aid + communication (DA+C) tool; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Baltimore, Maryland • Worcester, Massachusetts

Conditions: Arthritis, Rheumatoid
Interventions: CNTO 136 100 mg, CNTO 136 50 mg, CNTO 136 25 mg, Placebo, Methotrexate; Drug
Lead sponsor: Centocor, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 8
States / cities: Aventura, Florida • Lexington, Kentucky • Frederick, Maryland + 5 more

Conditions: Opioid Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe
Interventions: TRTME; Behavioral
Lead sponsor: T. John Winhusen, PhD; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Lymphoblastic Lymphoma
Interventions: Prednisone, Vincristine, Daunorubicin, PEG-asparaginase, Erwinia asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine, Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Hydrocortisone, Etoposide; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 2
States / cities: San Diego, California • Memphis, Tennessee

Conditions: Obesity
Interventions: Angiotensin-(1-7), Saline; Drug
Lead sponsor: Amy Arnold; Other
Eligibility: 18 Years to 60 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Tobacco Use
Interventions: Staff training and academic detailing; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 1,365 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program

Preparedness Study - HPV Vaccine

Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

The Protective Effect of Friendship on Peer Rejection in Overweight and Normal Weight Youth

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial

Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women

Explorations of the Benefits of the ZeroG TRiP System to Improve Balance in Patients Following Stroke

Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear

HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies

Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage

Evaluating Within-Person and Between-Person Effects Of A Personalized Normative Feedback Intervention On Drinking As They Are Moderated By Self-Determination

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

An mHealth Mobile Application Supporting Maintenance of Physical Activity Among Men and Women With High Blood Pressure

Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer

Zinc as an Adjunctive Therapy for Cervical Dystonia

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Simulated Passive Jogging & Jumping Devices & NO

Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma

Angiotensin-(1-7) and Energy Expenditure in Human Obesity

Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics